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Fever is common among patients seeking care in sub-Saharan Africa (sSA), but causes
other than malaria are rarely diagnosed. We assessed dengue and chikungunya virus infec-
tions among young febrile adults evaluated for acute HIV infection (AHI) and malaria in
coastal Kenya.
Methods
We tested plasma samples obtained in a cross-sectional study from febrile adult patients
aged 18–35 years evaluated for AHI and malaria at urgent care seeking at seven health
facilities in coastal Kenya in 2014–2015. Dengue virus (DENV) and chikungunya virus
(CHIKV) were amplified using quantitative real-time reverse-transcription polymerase chain
reaction. We conducted logistic regression analyses to determine independent predictors of
dengue virus infection.
Results
489 samples that were negative for both AHI and malaria were tested, of which 43 (8.8%,
95% confidence interval [CI]: 6.4–11.7) were positive for DENV infection. No participant was
positive for CHIKV infection. DENV infections were associated with clinic visits in the rainy
season (adjusted odds ratio (AOR) = 3.0, 95% CI: 1.3–6.5) and evaluation at a private health
facility (AOR 5.2, 95% CI: 2.0–13.1) or research health facility (AOR = 25.6, 95% CI: 8.9–
73.2) instead of a public health facility.
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Conclusion
A high prevalence of DENV infections was found in febrile young adult patients evaluated
for AHI. Our data suggests that DENV, along with AHI and malaria, should be considered in
the differential diagnosis of the adult patient seeking care for fever in coastal Kenya.
Introduction
Fever is a common symptom among persons seeking healthcare in developing countries [1].
While various illnesses may prompt individuals to seek healthcare for fever, non-malarial
febrile illnesses remain largely undiagnosed at many front-line health facilities due to a wide a
range of potential aetiologies, overlapping clinical presentation and lack of diagnostic capacity
[2]. With the World Health Organization’s (WHO) 2010 recommendation to confirm malaria
infection by microscopy or by rapid diagnostic test (RDT) in patients presenting with a history
of fever, the proportion of fevers that are recognized as likely due to diseases other than malaria
is increasing [3].
There is little data on the aetiology of fevers in adults presenting for care in sub-Saharan
Africa (sSA). In a systematic review of adults seeking outpatient care from clinics in sSA in the
period 2003–2014, 34 (79%) of 43 studies identified focused on malaria only. The remaining
studies investigated the following aetiologies: acute HIV-1 infection (AHI) and malaria (2
studies), human herpes virus-8 and hepatitis B virus (1 study), pneumococcal bacteraemia (1
study), flaviviruses (1 study), influenza viruses (1 study), Lassa virus (1 study), intestinal hel-
minths (1 study) and schistosomiasis (1 study) [4].
Several seroprevalence studies have reported exposure to arbovirus infections including
dengue virus (DENV) chikungunya virus (CHIKV) and O’Nyong Nyong (ONNV) infection
in coastal Kenya [5–7]. Due to limited surveillance and lack of diagnostic capacity to screen for
arboviral infections among patients seeking care, little is known on disease burden and trans-
mission during interepidemic periods.
Dengue fever was first documented on the Kenyan coast during an outbreak in Malindi in
1982 [8], and more recently in Mombasa in 2013 [9] while chikungunya fever outbreaks were
reported from Lamu and Mombasa in 2004 [10]. However, no assessment of DENV and
CHIKV has been conducted outside of outbreaks among adult febrile patients seeking care in
coastal Kenya. A recent study documented ongoing CHIKV transmission in Kwale County,
south of Mombasa [7]. Laboratory diagnosis of CHIKV and DENV during acute phase of ill-
ness can be done through virus isolation or real-time reverse-transcription polymerase chain
reaction (RT-PCR) [11–13]. In a study by Riswari et al., CHIKV viremia preceded fever onset
by up to six days, and CHIKV quantitative (qRT-PCR) testing on serial specimens indicated
that viremia lasted for 11–13 days [14]. DENV can be detected by RT-PCR two to ten days
after onset of illness [15].
In 2013, a year of low malaria transmission in coastal Kenya, we conducted a pilot study on
acute febrile illness and reported that 1.7% of young febrile adults who were seronegative or
serodiscordant for HIV-1 had AHI and another 1.7% had malaria [16]. As less than 4% of
fevers in pilot study participants enrolled in 2013 could be explained we set out to assess
whether CHIKV or DENV were other causes of febrile illness in patients enrolled in the ongo-
ing study.
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Methods
Study setting
The study was conducted in two nearby towns in Kilifi County along the Kenyan coast: Mtwapa,
which is situated 16 km north-east of Mombasa, and Kilifi, which is situated 42 km further
north along the Mombasa-Malindi Road. The region experiences warm weather throughout the
year with two rainy seasons, the long rainy season starting in March and lasting through June (4
months), and a shorter rainy period starting in October and continuing through December (3
months) [17]. The annual average temperature ranges between 26.5˚C and 34.0˚C (high) and
22.5˚C and 24.5˚C (low). The region has an average relative humidity of 60%.
Study design
This was a cross-sectional study nested within an ongoing AHI study conducted between Feb-
ruary 2014 and January 2015. Study volunteers were recruited from six health facilities in
Mtwapa, including four private clinics, one research clinic operated by the Kenya Medical
Research Institute, and one government health centre. In Kilifi, the Kilifi County Hospital was
the only participating health facility. Study enrolments in Kilifi County hospital started mid-
June 2014, at the end of the long rainy season.
As part of a standardized protocol, patients aged between 18 and 35 years who sought
urgent health care at these facilities were screened for eligibility. Potentially eligible partici-
pants were assigned a risk score by summing points based on the following signs and symp-
toms and reported risk behaviour: one point each for generalized body pains or multiple
partners in the past two months and two points each for documented fever (37.5˚C axillary),
reported diarrhoea, or symptoms compatible with a sexually transmitted infection including
signs such as discharge or genital ulcers [16]. Inclusion criteria included age 18–35 years, a risk
score of at least two, and willingness to be evaluated for acute or prevalent HIV-1 infection
and, if febrile, for malaria. Patients with known HIV-1-seropositive status were excluded. Par-
ticipants were also recruited for this study at five selected pharmacies in Mtwapa, and referred
to any of the six health facilities for screening as described previously [16]. The Kiswahili name
of the study was ‘Tambua Mapema’, which means “test early.”
Study procedures
After obtaining written informed consent from eligible volunteers, a trained clinician from
each respective facility collected demographic information, obtained a standardised clinical
history including onset of illness, symptoms and signs present at health care seeking, and per-
formed a targeted physical exam.
A 5-ml sample of venous blood was collected into EDTA. Onsite HIV-1 testing using two
rapid diagnostic tests (RDT) Alere Determine™ HIV-1/2, (Alere Medical, Tokyo, Japan) and
Uni-Gold™ (Trinity Biotech plc, Bray, Ireland) was done in parallel. Participants with docu-
mented fever were also tested for malaria using an RDT (Optimal, Flow Inc., Portland, Ore-
gon, USA). All malaria-positive results were confirmed at the KEMRI-Wellcome Trust
laboratories in Mtwapa and Kilifi using the same RDT test kit. Plasma was then separated and
stored at -80˚C in Kilifi, until further testing at the KEMRI-Centers for Disease Control and
Prevention. Plasma was initially stored at a -20˚C at the satellite laboratory in Mtwapa.
Laboratory methods
In our study we used qRT-PCR to diagnose DENV or CHIKV infection. Automated Viral
RNA extraction was done from 200 μL of plasma samples using the NucliSens easyMAG
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system (bioMerieux South Africa) according to the manufacturer’s instructions. Nucleic acid
was recovered in 60 μL of elution buffer.
DENV was detected using the CDC DENV-1-4 real time RT-PCR assay kit for both diagno-
sis and identification of DENV serotypes using SuperScript™ III Platinum1 One-Step qRT-
PCR system (Invitrogen, Carlsbad, California, USA) according to the manufacturer’s instruc-
tions and as previously described [15, 18].
CHIKV was detected using the AgPath-ID One-step RT-PCR Kit (Applied biosystems
Carlsbad, California, USA) in a total reaction volume of 25 μL containing 5μL of RNA, 4.5 μL
nuclease free water, 12.5 μL 2X RT-PCR buffer, 1μL of 25X RT-PCR enzyme mix, 0.8 μL of 20
picomoles forward (CHIK243–50 GAY CCC GAC TCA ACC ATC CT 30) and reverse primers
(CHIK330–50 CAT MGG GCA RAC GCA GTG GTA 30) and 0.4 μL of 5 picomoles of the
probe (CHIK273–50 FAM-AG YGC GCC AGC AAG GAG GAK GAT GT-BHQ1 30). Reac-
tions were run in 96-well plates in the ABI 7500 FAST Dx thermocycler (Applied Biosystems,
Foster city, California, USA) in the following cycling conditions: 45˚C for 10 minutes, 95˚C
for 10 minutes, 45 cycles of 95˚C for 15 seconds and 55˚C for 1 minute.
Data analysis
Overall prevalence was determined as a percentage of participants with detectable DENV and
CHIKV infections over the total number of participants included. Exact 95% binomial confi-
dence intervals (CIs) were calculated for prevalence estimates. Associations between binary or
categorical variables were investigated using chi-square tests.
Bivariate logistic regression was used to determine associations with DENV infection (no
CHIKV infections were observed). Variables significant at p0.05 in bivariate analysis were
entered into a multivariable model to identify independent associations with DENV. Crude
and adjusted odds ratios (AOR) were calculated, with 95% confidence intervals (CI) and likeli-
hood ratio test p-values. All analyses were done using STATA version 13.1 (StataCorp, College
Station, Texas, USA).
Ethical consideration
The study was approved by the KEMRI Scientific and Ethics Review Unit, and by the Univer-
sity of Oxford. All participants provided written informed consent for study participation.
Results
Characteristics of study participants
Among 5,041 participants aged 18–35 years seeking outpatient care, 994 were eligible and
enrolled in the study, of whom 672 were febrile (Fig 1). We excluded 98 (14.6%) participants
diagnosed with malaria, 2 (0.3%) participants diagnosed with AHI and 2 (0.3%) participants
co-infected with malaria and AHI. Of the 570 remaining participants who were eligible for
DENV and CHIKV assessment, 79 (13.9%) were excluded due to insufficient sample volume
and 2 (0.3%) had not consented to testing for other causes of fever. In total, 489 participants
were assessed for DENV and CHIKV infection (Fig 1).
Of the 489 participants included, 188 (38.4%) were men and 301 (61.6%) were women.
Most were aged 18–24 years, married, and educated at the primary level or below. Half of the
participants were unemployed, and about two thirds of all participants were enrolled in study
sites from Mtwapa. Approximately 58% of the participants enrolled during the long and
short rainy seasons. Almost half had first sought care elsewhere before visiting the study site,
including one in six who had visited a pharmacy, while less than one in ten participants had a
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Fig 1. Flow chart of outpatients aged 18–35 years screened for evaluation at care seeking in Kilifi or Mtwapa,
February 2014 –January 2015.
doi:10.1371/journal.pone.0167508.g001
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documented referral from a study pharmacy. About two thirds were evaluated at a government
health facility, with the majority of individuals presenting within 7 days of onset of symptoms
and reporting multiple symptoms (Table 1). The overall prevalence of newly diagnosed HIV-1
was 5.1% (3.2% in men and 6.3% in women, p = 0.1).
Prevalence of DENV and CHIKV
None of the samples was positive for chikungunya virus infection. A total of 43 (8.8%, 95% CI:
6.4–11.7) participants tested positive for dengue virus infection. All samples were positive for
DENV serotype 2, and one sample was also positive for serotype 3. Overall, the prevalence for
DENV was 0% in Kilifi vs. 12.8% in Mtwapa (p = 0.001). However the prevalence of DENV
infections among patients attending government facilities in Kilifi and Mtwapa was 0% (0/
154) and 1.9% (3/159, p = 0.087) respectively (data not shown). The majority of dengue infec-
tions were observed during the long rains with peak transmission in June (Fig 2).
In bivariate analysis, DENV infections were more common among participants who were
single, had a secondary education level or higher, were formally or self-employed, were
referred from a study pharmacy or were seen at the KEMRI research clinic (Table 2).
In multivariable analysis, summarized in Table 2, independent predictors associated with
DENV included presenting during the rainy season (AOR = 3.0, 95% CI: 1.3–6.5) and evalua-
tion at a private health facility (AOR 5.2, 95% CI: 2.0–13.1) or the KEMRI research clinic
(AOR = 25.6, 95% CI: 8.9–73.2), compared to a government facility.
Participants with DENV were less likely to report sore throat (9.3% vs. 25.3%, p = 0.019) or
diarrhoea (2.3% vs. 12.3%, p = 0.049) and more likely to report generalised myalgia (86.1% vs.
72.0%, p = 0.047), compared to participants without DENV (Fig 3). However, with only 43
DENV infections, the absolute number of symptoms or signs in DENV infected patients was
small and clinical predictors were not included in the multivariable analysis.
Discussion
We documented a substantial prevalence of DENV in young adult febrile patients seeking care
at outpatient departments in coastal Kenya. While DENV was first reported in Kenya in the
early 1980s during an epidemic in the coastal towns of Kilifi and Malindi [8], to our knowl-
edge, this was the first study assessing the prevalence of DENV and associated factors among
symptomatic patients seeking outpatient care outside of an epidemic.
All infections were identified in Mtwapa, a peri-urban town, located 16 km north-east of
Mombasa, where an outbreak of DENV was reported in 2013 [9]. DENV infections identified
in Mtwapa in 2014 likely reflect ongoing transmission following the DENV epidemic in
Mombasa. Localised transmission of DENV during the rainy season is common as has been
reported in Thailand and Gabon [19, 20], as dengue-transmitting Aedes mosquitoes are abun-
dant during rains [21]. Surprisingly, participants with DENV were more likely to be diagnosed
at private facilities or the KEMRI research clinic, which may reflect a selection bias, with symp-
tomatic patients being more likely to seek care at these sites.
None of the participants tested positive for CHIKV. CHIKV infections have been reported
in non-immune adults and children in Africa including Kenya [10, 22, 23]. We may not have
detected CHIKV in our study population due to prior immunity in the young adult study pop-
ulation, or because CHIKV transmission may have been low in the study area in 2014. Simi-
larly, we did not detect DENV among 154 febrile participants assessed in Kilifi, suggesting that
DENV transmission may at times be localised. Our study did not assess for ONNV infection
as we were not aware of ongoing ONNV transmission in Coastal Kenya at the time of planning
the study [7]. Interestingly, in a follow up study characterising viral nucleic acids present in
Dengue and Chikungunya Virus Infections among Febrile Adults in Coastal Kenya
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Table 1. Demographic and clinical characteristics of study participants (N = 489).
Total (n = 489) Male (n = 188) Female (n = 301)
Demographic characteristics
Age group (years)
18–24 277 (56.6) 104 (55.3) 173 (57.5)
25–30 134 (27.4) 49 (26.1) 85 (28.2)
31–35 78 (16.0) 35 (18.6) 43 (14.3)
Marital status
Single 224 (45.8) 126 (67.0) 98 (32.6)
Ever married 264 (54.0) 62 (33.0) 202 (67.1)
Missing 1 (0.2) 0 (0.0) 1 (0.3)
Education
No or primary level education 269 (55.0) 70 (37.2) 199 (66.1)
Secondary or higher education 219 (44.8) 118 (62.8) 101 (33.6)
Missing education 1 (0.2) 0 (0.0) 1 (0.3)
Employment status
Unemployed 247 (50.5) 54 (28.7) 193 (64.1)
Employed 242(49.5) 134(71.3) 108 (35.9)
Residence
Mtwapa 335 (68.5) 153 (81.4) 182 (60.5)
Kilifi 154 (31.5) 35 (18.6) 119 (39.5)
Seasonal variation
Dry season (January, February, July, August, September) 204 (41.7) 103 (54.8) 182 (60.5)
Rainy season (March through June, October through December) 285 (58.3) 85 (45.2) 119 (39.5)
Health care seeking before study enrolment
Did not seek care elsewhere 267 (54.6) 94 (50.0) 173 (57.5)
Sought care elsewhere* 222 (45.4) 94 (50.0) 128 (42.5)
Referred from a study pharmacy with a referral card
No 451 (92.2) 160 (85.1) 291 (96.7)
Yes 38 (7.8) 28 (14.9) 10 (3.3)
Evaluated at
Government health facility or hospital 336 (68.7) 94 (50.0) 242 (80.4)
Private health facility 122 (25.0) 79 (42.0) 43 (14.3)
KEMRI research clinic 31 (6.3) 15 (8.0) 16 (5.3)
Clinical presentation
Reported duration of illness
Less than 7 days 423 (86.5) 159 (84.6) 264 (87.7)
More than 7 days 66 (13.5) 29 (15.4) 37 (12.3)
Clinical presentation
Fever only 34 (6.9) 18 (9.6) 16 (5.3)
Fever and other symptoms and signs** 455 (93.1) 170 (90.4) 285 (94.7)
HIV status
Negative 464 (94.9) 182 (96.8) 282 (93.7)
Positive 25 (5.1) 6 (3.2) 19 (6.3)
*Sought care elsewhere included: seeking care at a pharmacy (83), purchase of medication from a retail shop (73), having visited a different clinic other
than the study site for the current illness (54), having visited the same clinic for the current illness (4), and use of medication prescribed during a previous
illness (8).
**Other symptoms included: Headache (400), generalised myalgia (358), loss of appetite (245), sore throat (117), vomiting (61), diarrhoea (56), abnormal
respiratory rate (33), conjunctivitis (6) and lymphadenopathy (50) (note: patients had multiple signs and symptoms).
doi:10.1371/journal.pone.0167508.t001
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pooled plasma samples of 498 febrile patients through viral metagenomics (438 (88%) of
plasma samples belonged to the present study), we detected DENV virus, but no CHIKV, or
other alphaviruses (Ngoi et al, JVI, in press).
Our study highlights the importance of knowing the local differential diagnosis of febrile
patients in resource-limited settings [2]. In addition to testing for malaria as recommended by
the WHO, clinicians attending to febrile adult patients should provide HIV-1 testing, as febrile
patients are more often HIV-infected [2, 16]. In facilities with the capacity for AHI testing
[24, 25], clinicians should test patients who meet risk or symptom criteria for AHI [25, 26].
Although patients with DENV had more frequent generalised body pains, and less frequent
sore throat or diarrhoea than patients without DENV, these characteristics were not helpful in
identifying DENV among participants evaluated.
Our study had some limitations. First, we only included young adult patients evaluated
within an AHI screening study at two sites in a small area of the Kenyan coast. Our study pop-
ulation from Kilifi only included patients reporting to a government hospital. We did not
include patients reporting to private facilities or a research facility in Kilifi, nor did we recruit
patients through pharmacies in Kilifi. Second, we excluded patients diagnosed with malaria or
AHI; as we wanted to describe unknown causes of fever among non-malarial febrile illnesses.
AHI and DENV coinfection has not been reported to our knowledge; concurrent DENV and
malaria infection due Plasmodium falciparum or plasmodium vivax are rare [27], and both
transmission vectors and transmission season are different [20]. Taken together, excluding
patients with AHI or malaria represented approximately 15% of the study population and thus
likely do not represent a significant bias. Third, we did not ask questions about factors previ-
ously associated with DENV, such as use of mosquito net or mosquito repellent, or recent
travel outside Kenya [9]. Differences in these risk factors between participants recruited at our
different study sites may have explained the different prevalence we found in Mtwapa.
Despite these limitations, we showed that DENV infections are an important cause of
febrile illness among young adult patients seeking outpatient care in coastal Kenya. Ongoing
Fig 2. Study participants with and without dengue viral infection (N = 489).
doi:10.1371/journal.pone.0167508.g002
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surveillance for dengue viral infections and other arboviruses is recommended, and detection
should lead to intensified effort to minimise mosquito breeding sites and promote personal
protective measures. As causes of fever will largely remain undiagnosed without affordable
and reliable point-of-care diagnostics, it is hoped that such tests will be developed in the
Table 2. Bivariate and Multivariable analysis of demographic and clinical characteristics of febrile patients with dengue virus infection aged 18–35
years seeking care in Mtwapa or Kilifi, February 2014- January 2015 (N = 489).
Acute dengue infection, n (%) Bivariate analysis Multivariable analysis
COR (95% CI) P value AOR (95% C.I) P-value
Demographic characteristics
Gender
Male 20 (10.6) Ref1
Female 23 (7.6) 0.7 (0.4–1.3) 0.260 - -
Age group
18–24 years 27 (9.8) Ref
25–30 years 8 (6.0) 0.6 (0.3–1.3)
31–35 years 8 (10.3) 1.1 (0.5–2.4) 0.370 - -
Marital status
Single 27 (12.1) 2.1 (1.1–4.1) 0.020 1.6 (0.8–3.4) 0.222
Ever married 16 (6.1) Ref Ref
Education level
Primary level education or less 14 (5.2) Ref Ref
Secondary or higher education 29 (13.2) 2.8 (1.4–5.4) 0.001 1.3 (0.6–28) 0.586
Employment status
Unemployed 15 (6.1) Ref Ref
Employed 28 (11.6) 2.0 (1.1–3.9) 0.031 1.5 (0.7–3.2) 0.317
Season of study visit
Dry season (January, February, July, August, September) 12 (5.9) Ref Ref
Rainy season (March through June, October through
December)
31 (10.9) 2.0 (1.0–3.9) 0.050 3.0 (1.3–6.5) 0.004
Health seeking behaviour before visiting study sites
Did not seek care elsewhere 22 (8.2) Ref
Sought care elsewhere 21 (9.5) 1.2 (0.6–2.2) 0.636 - -
Referred from a study pharmacy with a referral card
No 32 (7.1) Ref Ref
Yes 11 (29.0) 5.3 (2.4–11.7) < 0.001 1.9 (0.7–4.8) 0.178
Evaluated at
Government facility 9 (2.7) Ref Ref
Private facility 20 (16.4) 7.1 (3.1–16.1) 5.2 (2.0–13.1)
Research clinic 14 (45.2) 29.9 (11.3–
78.8)




Presenting with fever only 2 (5.9) Ref - -
Presenting with fever and other symptoms2 41 (9.0) 1.6 (0.4–6.9) 0.512 - -
HIV status
HIV negative 42 (9.0) Ref
HIV positive 1 (4.0) 0.4 (0.1–3.1) 0.337 - -
1 Reference
2 Other symptoms included: headache, generalised myalgia, loss of appetite, sore throat, vomiting, diarrhoea, respiratory rate, conjunctivitis and
lymphadenopathy
doi:10.1371/journal.pone.0167508.t002
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foreseeable future. In conclusion, our study documented a relatively high prevalence of DENV
in young febrile adults in Mtwapa. Dengue fever should be considered in the differential diag-
nosis of the febrile adult patient in Kenya.
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